[HTML][HTML] Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - Oncotarget, 2016 - ncbi.nlm.nih.gov
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …
several types of human cancers, particularly squamous cell carcinomas. We previously …
Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - Oncotarget, 2016 - hero.epa.gov
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …
several types of human cancers, particularly squamous cell carcinomas. We previously …
[PDF][PDF] Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - nagoya.repo.nii.ac.jp
ABSTRACT CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly
expressed in several types of human cancers, particularly squamous cell carcinomas. We …
expressed in several types of human cancers, particularly squamous cell carcinomas. We …
Suppression of skin tumorigenesis in CD109-deficient mice.
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - Oncotarget, 2016 - europepmc.org
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …
several types of human cancers, particularly squamous cell carcinomas. We previously …
[引用][C] Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - Oncotarget, 2016 - cir.nii.ac.jp
Suppression of skin tumorigenesis in CD109-deficient mice | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - pdfs.semanticscholar.org
ABSTRACT CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly
expressed in several types of human cancers, particularly squamous cell carcinomas. We …
expressed in several types of human cancers, particularly squamous cell carcinomas. We …
[HTML][HTML] Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - Oncotarget, 2016 - oncotarget.com
Suppression of skin tumorigenesis in CD109-deficient mice | Oncotarget Online ISSN: 1949-2553
Search: Oncotarget Home Editorial Board Submission Current Volume Archive Scientific …
Search: Oncotarget Home Editorial Board Submission Current Volume Archive Scientific …
Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - 2016 - crick.figshare.com
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …
several types of human cancers, particularly squamous cell carcinomas. We previously …
Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato… - …, 2016 - pubmed.ncbi.nlm.nih.gov
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …
several types of human cancers, particularly squamous cell carcinomas. We previously …
[PDF][PDF] Suppression of skin tumorigenesis in CD109-deficient mice
M Sunagawa, S Mii, A Enomoto, T Kato, Y Murakumo… - 2016 - crick.figshare.com
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …
several types of human cancers, particularly squamous cell carcinomas. We previously …